Who owns Revolution Medicines, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of RVMD from SEC Form 13F filings across 693 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 693 institutions disclosed 213.9M shares of Revolution Medicines, Inc. worth $40.12B — about 101.4% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
693
13F holders
$40.12B
value, 2026 filers
101.4%
of shares outstanding (213.9M sh)
250
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of RVMD's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 13.7M | $2.56B | 0.0% | 6.5% | +22.1% |
| 2 | FARALLON CAPITAL MANAGEMENT, L.L.C. | 13.6M | $2.54B | 11.7% | 6.4% | -0.4% |
| 3 | FMR LLC | 12.2M | $2.28B | 0.1% | 5.8% | +44.1% |
| 4 | BAKER BROS. ADVISORS LP | 11.4M | $2.14B | 10.7% | 5.4% | +19.8% |
| 5 | Jupiter Topco LLCNEW | 10.7M | $2.01B | 0.8% | 5.1% | new |
| 6 | Darwin Global Management, Ltd. | 10.6M | $2.05B | 54.5% | 5% | +380.8% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 9.1M | $1.70B | 0.0% | 4.3% | +8.7% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.3M | $1.55B | 0.1% | 3.9% | +10.6% |
| 9 | Nextech Invest Ltd. | 7.6M | $1.42B | 67.6% | 3.6% | 0.0% |
| 10 | Paradigm Biocapital Advisors LP | 6.4M | $1.19B | 22.3% | 3% | -4.4% |
| 11 | UBS Group AG | 5.4M | $1.02B | 0.1% | 2.6% | +24.2% |
| 12 | STATE STREET CORP | 4.9M | $917.1M | 0.0% | 2.3% | +11.2% |
| 13 | Capital World InvestorsNEW | 4.0M | $750.7M | 0.1% | 1.9% | new |
| 14 | GEODE CAPITAL MANAGEMENT, LLC | 3.9M | $736.8M | 0.0% | 1.9% | +18.1% |
| 15 | WELLINGTON MANAGEMENT GROUP LLP | 3.8M | $719.8M | 0.1% | 1.8% | -36.2% |
| 16 | JPMORGAN CHASE & CO | 3.3M | $636.9M | 0.0% | 1.6% | +994.3% |
| 17 | BVF INC/IL | 3.0M | $555.3M | 14.2% | 1.4% | +3.8% |
| 18 | Alphabet Inc. | 2.9M | $551.8M | 0.6% | 1.4% | -10.5% |
| 19 | Casdin Capital, LLC | 2.6M | $482.7M | 24.2% | 1.2% | 0.0% |
| 20 | DEERFIELD MANAGEMENT COMPANY, L.P. | 2.4M | $448.0M | 4.7% | 1.1% | +4.1% |
| 21 | PRICE T ROWE ASSOCIATES INC /MD/ | 2.4M | $447.7M | 0.0% | 1.1% | -26.0% |
| 22 | Avoro Capital Advisors LLC | 2.3M | $430.2M | 3.9% | 1.1% | -2.0% |
| 23 | NORGES BANKNEW | 2.2M | $404.1M | 0.0% | 1% | new |
| 24 | GOLDMAN SACHS GROUP INC | 2.1M | $399.5M | 0.0% | 1% | -2.4% |
| 25 | Nearwater Capital Markets, Ltd | 2.1M | $392.7M | 6.8% | 1% | +209.3% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.